Multiple Sclerosis: Evaluation of Purine Nucleotide Metabolism in Central Nervous System in Association with Serum Levels of Selected Fat-Soluble Antioxidants

Article English OPEN
Kuračka, Ľubomír ; Kalnovičová, Terézia ; Kucharská, Jarmila ; Turčáni, Peter (2014)
  • Publisher: Hindawi Publishing Corporation
  • Journal: Multiple Sclerosis International, volume 2,014 (issn: 2090-2654, eissn: 2090-2662)
  • Related identifiers: doi: 10.1155/2014/759808, pmc: PMC4033398
  • Subject: Neurology. Diseases of the nervous system | Research Article | RC346-429 | Article Subject

In the pathogenesis of demyelinating diseases including multiple sclerosis (MS) an important role is played by oxidative stress. Increased energy requirements during remyelination of axons and mitochondria failure is one of the causes of axonal degeneration and disability in MS. In this context, we analyzed to what extent the increase in purine catabolism is associated with selected blood lipophilic antioxidants and if there is any association with alterations in serum levels of coenzyme Q10. Blood serum and cerebrospinal fluid (CSF) samples from 42 patients with diagnosed MS and 34 noninflammatory neurologic patients (control group) were analyzed. Compared to control group, MS patients had significantly elevated values of all purine nucleotide metabolites, except adenosine. Serum lipophilic antioxidants γ-tocopherol, β-carotene, and coenzyme Q10 for the vast majority of MS patients were deficient or moved within the border of lower physiological values. Serum levels of TBARS, marker of lipid peroxidation, were increased by 81% in the MS patients. The results indicate that the deficit of lipophilic antioxidants in blood of MS patients may have a negative impact on bioenergetics of reparative remyelinating processes and promote neurodegeneration.
  • References (43)
    43 references, page 1 of 5

    Bö, L., Dawson, T. M., Wesselingh, S., Mörk, S., Choi, S., Kong, P. A., Hanley, D., Trapp, B. D.. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Annals of Neurology. 1994; 36 (5): 778-786

    Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., Turnbull, D. M.. Mitochondrial changes within axons in multiple sclerosis. Brain. 2009; 132 (5): 1161-1174

    Ortiz, G. G., Macías-Islas, M. Á., Pacheco-Moisés, F. P., Cruz-Ramos, J. A., Sustersik, S., Barba, E. A., Aguayo, A.. Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis. Disease Markers. 2009; 26 (1): 35-39

    Uttara, B., Singh, A. V., Zamboni, P., Mahajan, R. T.. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology. 2009; 7 (1): 65-74

    Dutta, R., Trapp, B. D.. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology. 2007; 68 (22): S22-S31

    Mickel, H. S.. Multiple sclerosis: a new hypothesis. Perspectives in Biology and Medicine. 1975; 18 (3): 363-374

    Karg, E., Klivényi, P., Németh, I., Bencsik, K., Pintér, S., Vécsei, L.. Nonenzymatic antioxidants of blood in multiple sclerosis. Journal of Neurology. 1999; 246 (7): 533-539

    Besler, H. T., Çomoǧlu, S.. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutritional Neuroscience. 2003; 6 (3): 189-196

    Waxman, S. G.. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nature Reviews Neuroscience. 2006; 7 (12): 932-941

    Black, J. A., Newcombe, J., Trapp, B. D., Waxman, S. G.. Sodium channel expression within chronic multiple sclerosis plaques. Journal of Neuropathology and Experimental Neurology. 2007; 66 (9): 828-837

  • Metrics
    No metrics available
Share - Bookmark